Nevada § 439.4937 Analysis of information, records and reports; investigation of trends

Nevada Statutes

§ 439.4937 — Analysis of information, records and reports; investigation of trends

Nevada § 439.4937

Title 40PUBLIC HEALTH AND SAFETY

Ch. 439Administration

REPORTING AND ANALYZING INFORMATION ON SICKLE CELL DISEASE AND ITS VARIANTS

This text of Nevada § 439.4937 (Analysis of information, records and reports; investigation of trends) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 439.4937 (2026).

Text

1.The Chief Medical Officer or a qualified person designated by the Administrator of the Division shall analyze the information obtained pursuant to NRS 439.4929 , 439.4931 and 439.4933 and the reports published pursuant to NRS 439.4935 to determine whether any trends exist in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population.

2.If the Chief Medical Officer or the person designated pursuant to subsection 1 determines that a trend exists in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population, the Chief Medical Officer or the person designated pursuant to subsection 1 shall work with appropriate governmental, educational

Free access — add to your briefcase to read the full text and ask questions with AI

1. The Chief Medical Officer or a qualified person designated by the Administrator of the Division shall analyze the information obtained pursuant to NRS 439.4929 , 439.4931 and 439.4933 and the reports published pursuant to NRS 439.4935 to determine whether any trends exist in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population.
2. If the Chief Medical Officer or the person designated pursuant to subsection 1 determines that a trend exists in the usage of and access to health care services by patients with sickle cell disease and its variants in a particular area or population, the Chief Medical Officer or the person designated pursuant to subsection 1 shall work with appropriate governmental, educational and research entities to investigate the trend, advance research in the trend and facilitate the treatment of sickle cell disease and its variants and associated disorders.